Stefan Ruhnke

Stefan Ruhnke (geb. Schmid) is an experienced professional in the pharmaceutical industry, currently serving as a Commercial Key Account Manager at MSD Switzerland since October 2019, with a focus on BCM Pan Tumor Initiatives and Commercial Operations. Previously, Stefan held various senior positions at MSD Sharp & Dohme GmbH from October 2014 to September 2019, specializing in oncology, vaccines, and diabetes. Prior to that, Stefan worked as a Product Manager at optimed Medizinische Instrumente GmbH and as a Sales Representative at Pharmexx GmbH. Additionally, a brief period of self-employment as a professional triathlete was followed by a research scientist role in neurobiology at the University of Tuebingen. Stefan Ruhnke earned a Diploma in Biology with a focus on Marketing from the University of Tübingen and also studied at Queen's University Belfast.